Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
14,965,850
-
Number of holders
-
24
-
Total 13F shares, excl. options
-
2,897,889
-
Shares change
-
+51,888
-
Total reported value, excl. options
-
$8,171,000
-
Value change
-
-$99,570
-
Number of buys
-
11
-
Number of sells
-
-10
-
Price
-
$2.82
Significant Holders of CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) as of Q1 2022
31 filings reported holding CPIX - CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value as of Q1 2022.
CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) has 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,897,889 shares
of 14,965,850 outstanding shares and own 19% of the company stock.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (644,763 shares), DIMENSIONAL FUND ADVISORS LP (633,904 shares), VANGUARD GROUP INC (377,984 shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (286,655 shares), ACADIAN ASSET MANAGEMENT LLC (188,243 shares), BERKSHIRE ASSET MANAGEMENT LLC/PA (182,141 shares), BlackRock Inc. (138,902 shares), TWO SIGMA ADVISERS, LP (103,818 shares), TWO SIGMA INVESTMENTS, LP (89,083 shares), and GEODE CAPITAL MANAGEMENT, LLC (72,236 shares).
This table shows the top 24 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.